Molecular surveillance of artemisinin resistance-related Pfk13 and pfcrt polymorphisms in imported Plasmodium falciparum isolates reported in eastern China from 2015 to 2019

BACKGROUND: Artemisinin-based combination therapy (ACT) has been recommended as the first-line treatment by the World Health Organization to treat uncomplicated Plasmodium falciparum malaria. However, the emergence and spread of P. falciparum resistant to artemisinins and their partner drugs is a si...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiangli, Feng, Jun, Xu, Yan, Yan, Ge, Zhou, Shuisen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719650/
https://www.ncbi.nlm.nih.gov/pubmed/36464686
http://dx.doi.org/10.1186/s12936-022-04398-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719650/
https://www.ncbi.nlm.nih.gov/pubmed/36464686
http://dx.doi.org/10.1186/s12936-022-04398-x

Ejemplares similares